Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 20 | 1.660 |
Why?
|
| Surgical Mesh | 11 | 2014 | 24 | 1.500 |
Why?
|
| Herniorrhaphy | 9 | 2018 | 36 | 1.420 |
Why?
|
| Postoperative Complications | 20 | 2018 | 841 | 1.200 |
Why?
|
| Hernia, Inguinal | 7 | 2016 | 21 | 1.150 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 80 | 1.000 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 134 | 0.940 |
Why?
|
| Laparoscopy | 13 | 2016 | 168 | 0.920 |
Why?
|
| Esophageal Neoplasms | 7 | 2002 | 46 | 0.840 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 33 | 0.680 |
Why?
|
| General Surgery | 4 | 2015 | 51 | 0.600 |
Why?
|
| Middle Aged | 42 | 2018 | 8303 | 0.570 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2015 | 20 | 0.550 |
Why?
|
| Gastroplasty | 1 | 2016 | 24 | 0.520 |
Why?
|
| Aged | 31 | 2018 | 8448 | 0.510 |
Why?
|
| Male | 45 | 2020 | 13813 | 0.510 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 25 | 0.500 |
Why?
|
| Gastric Bypass | 1 | 2016 | 49 | 0.490 |
Why?
|
| Carcinoma | 3 | 2016 | 66 | 0.470 |
Why?
|
| Treatment Outcome | 22 | 2018 | 3204 | 0.460 |
Why?
|
| Humans | 60 | 2020 | 25165 | 0.460 |
Why?
|
| Adult | 30 | 2018 | 7259 | 0.440 |
Why?
|
| Educational Measurement | 3 | 2015 | 49 | 0.430 |
Why?
|
| Female | 42 | 2018 | 14160 | 0.430 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2003 | 21 | 0.420 |
Why?
|
| Recurrence | 10 | 2017 | 274 | 0.420 |
Why?
|
| Quality Improvement | 4 | 2014 | 128 | 0.420 |
Why?
|
| Retrospective Studies | 25 | 2018 | 3185 | 0.410 |
Why?
|
| Hepatectomy | 6 | 2015 | 54 | 0.390 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 58 | 0.390 |
Why?
|
| Liver Neoplasms | 5 | 2000 | 90 | 0.380 |
Why?
|
| Esophagectomy | 5 | 2002 | 22 | 0.370 |
Why?
|
| Colectomy | 3 | 2016 | 19 | 0.370 |
Why?
|
| Curriculum | 2 | 2003 | 123 | 0.360 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 3 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 5 | 2013 | 87 | 0.330 |
Why?
|
| Aged, 80 and over | 13 | 2017 | 4508 | 0.300 |
Why?
|
| Students, Medical | 2 | 2013 | 46 | 0.280 |
Why?
|
| Risk Factors | 9 | 2018 | 2179 | 0.280 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2007 | 71 | 0.270 |
Why?
|
| Survival Rate | 9 | 2015 | 290 | 0.260 |
Why?
|
| Prospective Studies | 9 | 2014 | 1618 | 0.260 |
Why?
|
| Smoking | 2 | 2016 | 169 | 0.240 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 13 | 0.230 |
Why?
|
| Polypropylenes | 1 | 2003 | 1 | 0.210 |
Why?
|
| Prognosis | 6 | 2017 | 693 | 0.210 |
Why?
|
| Gastrectomy | 3 | 2015 | 23 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 1672 | 0.200 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 8 | 0.200 |
Why?
|
| Ultrasonography | 4 | 2020 | 208 | 0.200 |
Why?
|
| Cholangiography | 4 | 2015 | 7 | 0.200 |
Why?
|
| Colorectal Neoplasms | 4 | 1997 | 107 | 0.190 |
Why?
|
| Laparotomy | 3 | 2020 | 17 | 0.190 |
Why?
|
| Hernia, Femoral | 1 | 2001 | 1 | 0.180 |
Why?
|
| United States | 9 | 2016 | 1928 | 0.180 |
Why?
|
| Mesenteric Cyst | 1 | 2020 | 3 | 0.170 |
Why?
|
| Lymphokines | 1 | 2000 | 6 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 7 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 7 | 0.170 |
Why?
|
| Adolescent | 6 | 2007 | 2018 | 0.170 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 33 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2020 | 54 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 34 | 0.170 |
Why?
|
| Peritoneum | 2 | 2003 | 15 | 0.170 |
Why?
|
| Pneumonia | 2 | 2016 | 63 | 0.160 |
Why?
|
| Suture Techniques | 3 | 2007 | 142 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1997 | 171 | 0.160 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 80 | 0.160 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2018 | 3 | 0.150 |
Why?
|
| Cholelithiasis | 1 | 1998 | 6 | 0.150 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 7 | 0.150 |
Why?
|
| Cholecystectomy | 3 | 2013 | 9 | 0.150 |
Why?
|
| Gallstones | 1 | 1998 | 5 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 184 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2018 | 18 | 0.150 |
Why?
|
| Liver | 2 | 1997 | 129 | 0.150 |
Why?
|
| Internship and Residency | 3 | 2015 | 171 | 0.140 |
Why?
|
| Survival Analysis | 6 | 2015 | 231 | 0.140 |
Why?
|
| Lipoma | 1 | 2017 | 4 | 0.140 |
Why?
|
| Myoepithelioma | 1 | 2017 | 2 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 22 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2003 | 241 | 0.140 |
Why?
|
| Databases, Factual | 5 | 2016 | 318 | 0.140 |
Why?
|
| Trachea | 1 | 1997 | 39 | 0.140 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1996 | 3 | 0.130 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Portal Vein | 1 | 1996 | 38 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 1997 | 147 | 0.130 |
Why?
|
| Thrombosis | 1 | 1996 | 51 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 23 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 6 | 0.120 |
Why?
|
| Fundoplication | 2 | 2013 | 22 | 0.120 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 4 | 0.120 |
Why?
|
| Organs at Risk | 1 | 2015 | 7 | 0.120 |
Why?
|
| Hospital Costs | 1 | 1996 | 57 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 23 | 0.120 |
Why?
|
| Clinical Competence | 3 | 2013 | 182 | 0.120 |
Why?
|
| Liver Regeneration | 1 | 1995 | 20 | 0.120 |
Why?
|
| Radiation Oncology | 1 | 2015 | 13 | 0.120 |
Why?
|
| Neoplasm Staging | 5 | 2015 | 331 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 69 | 0.120 |
Why?
|
| Esophagus | 2 | 2012 | 55 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 428 | 0.120 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 6 | 0.120 |
Why?
|
| Logistic Models | 4 | 2016 | 377 | 0.120 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 51 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 14 | 0.120 |
Why?
|
| Safety | 2 | 2007 | 37 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 14 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 14 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 31 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 36 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 105 | 0.110 |
Why?
|
| Sarcoma | 1 | 2015 | 65 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 836 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 305 | 0.110 |
Why?
|
| Pain, Postoperative | 3 | 2013 | 295 | 0.110 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2014 | 29 | 0.110 |
Why?
|
| Cholestasis | 1 | 1993 | 6 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 29 | 0.110 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 3 | 0.110 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 3 | 0.110 |
Why?
|
| Length of Stay | 5 | 2014 | 295 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 243 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 32 | 0.110 |
Why?
|
| Operative Time | 4 | 2014 | 86 | 0.100 |
Why?
|
| Stents | 1 | 1993 | 75 | 0.100 |
Why?
|
| Abdominal Wall | 1 | 2013 | 6 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 39 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 109 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 66 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 287 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 145 | 0.100 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 24 | 0.100 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 18 | 0.100 |
Why?
|
| Time Factors | 4 | 2014 | 1336 | 0.100 |
Why?
|
| Morbidity | 3 | 2014 | 50 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 25 | 0.080 |
Why?
|
| Reoperation | 5 | 2016 | 847 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2013 | 109 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 318 | 0.080 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2007 | 6 | 0.070 |
Why?
|
| Omentum | 1 | 2007 | 5 | 0.070 |
Why?
|
| Chicago | 2 | 2001 | 916 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 120 | 0.070 |
Why?
|
| Child | 3 | 2001 | 1211 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 712 | 0.060 |
Why?
|
| Sutures | 2 | 2003 | 49 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 26 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 450 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 637 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 338 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1301 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 458 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 308 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 142 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 88 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 83 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 25 | 0.050 |
Why?
|
| Models, Educational | 1 | 2001 | 24 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2017 | 578 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1085 | 0.040 |
Why?
|
| Bile | 1 | 2020 | 5 | 0.040 |
Why?
|
| Intraoperative Care | 2 | 1998 | 41 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 10 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 10 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 15 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 67 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 86 | 0.040 |
Why?
|
| Infant | 1 | 2001 | 520 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 8 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 609 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1999 | 4 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 171 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 182 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 5 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1998 | 18 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 572 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 273 | 0.040 |
Why?
|
| Bronchial Neoplasms | 1 | 1997 | 5 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2017 | 12 | 0.040 |
Why?
|
| Pilot Projects | 2 | 1997 | 390 | 0.040 |
Why?
|
| Groin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 27 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 46 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 85 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 31 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 104 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 450 | 0.030 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1997 | 21 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 1996 | 1 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 1 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 1996 | 2 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2016 | 16 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 14 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 342 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 42 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 29 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 9 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 76 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 114 | 0.030 |
Why?
|
| Cardia | 1 | 1995 | 3 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 13 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 14 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 123 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 105 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 96 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 89 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 177 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 430 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 66 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 83 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 566 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 320 | 0.030 |
Why?
|
| Jejunum | 1 | 1994 | 10 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1994 | 5 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 22 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 138 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 121 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 59 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 231 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 370 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 5 | 0.030 |
Why?
|
| Rats | 1 | 1995 | 639 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 142 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 8 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Seroma | 1 | 2013 | 4 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 79 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 567 | 0.030 |
Why?
|
| Intraoperative Period | 3 | 1997 | 23 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 1999 | 442 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 557 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1772 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 594 | 0.020 |
Why?
|
| Animals | 1 | 1995 | 3427 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 23 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 24 | 0.020 |
Why?
|
| Blood Loss, Surgical | 2 | 1999 | 48 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 456 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2002 | 19 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 33 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 397 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1999 | 8 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 18 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 45 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 96 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 50 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 208 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 177 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 13 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 2 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 1032 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 87 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 60 | 0.010 |
Why?
|